Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
A woman wearing a yellow shirt smiles as she checks her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bell Potter has initiated coverage on Orica with a buy rating and a $23.00 price target, citing its transformation and expected growth in underlying EBIT, along with potential for increased shareholder returns through share buy-backs and dividends
  • Citi has upgraded Pro Medicus to a buy rating with a $350.00 target, highlighting its strong earnings growth outlook supported by long-term contracts, high renewal rates, and the potential growth facilitated by artificial intelligence.
  • UBS has maintained its buy rating on Zip Co with a price target of $5.25, driven by strong app download data in July and August indicating continued momentum and a positive outlook for FY 2026.

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Orica Ltd (ASX: ORI)

According to a note out of Bell Potter, its analysts have initiated coverage on this commercial explosives company's shares with a buy rating and $23.00 price target. The broker is feeling positive about Orica's outlook following its transformation in recent years. In fact, it expects the company to grow underlying EBIT across each segment in the short-to-medium term. Bell Potter also believes that the company is well positioned to deliver rapid de-leveraging over FY 2026 to FY 2027 (in the absence of M&A). It expects this to allow Orica's board to prioritise increasing shareholder returns via an extension to the share buy-back program and dividends. The Orica share price is trading at $21.23 on Friday.

Pro Medicus Ltd (ASX: PME)

A note out of Citi reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with a significantly improved price target of $350.00. Although Citi concedes that Pro Medicus shares trade on high multiples, it believes this is justified due to its strong earnings growth outlook. It notes that this is being underpinned by its sticky product offering, long contracts, high renewal rates, and an industry challenged by radiologist constraints. The broker has boosted its revenue growth estimates. It also highlights its belief that artificial intelligence will be supportive of Pro Medicus' growth and margin expansion in the medium term. The Pro Medicus share price is fetching $317.63 at the time of writing.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later (BNPL) provider's shares with an improved price target of $5.25. According to the note, the broker is feeling even more bullish on Zip's outlook after reviewing app store data. It highlights that the data indicates that downloads increased strongly in July and August, which bodes well for its performance in FY 2026 and indicates that its strong momentum is continuing. Especially given how resilient US retail sales have been. In light of this, it has boosted its earnings estimates for the medium term and its valuation to reflect this. The Zip share price is trading at $4.71 this afternoon.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man smiles as he holds bank notes in front of a laptop.
Broker Notes

Experts reckon both of these ASX stocks are good buys today!

These businesses could be compelling opportunities to buy today.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Broker Notes

Broker names 3 ASX shares to buy this week

Bell Potter has identified three shares that it is bullish on right now.

Read more »

Time to sell ASX 200 shares written on a clock.
Broker Notes

Experts name 3 ASX 200 giants to sell today

Leading investment experts are calling time on these three outperforming ASX 200 giants. But why?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

This ASX 200 stock has a 'strong runway' and offers a 24% total return

18% upside and a 6% dividend yield could be on offer with this stock according to Bell Potter.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Broker Notes

Bell Potter names more of the best ASX shares to buy in February

The broker has good things to say about these shares. Let's find out why.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Broker Notes

Bell Potter says these ASX 200 stocks are buys with 20%+ upside

The broker remains positive on these blue chips following their results releases.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: Bubs, Origin Energy, 4D Medical shares

Experts reveal their ratings on three ASX shares in the consumer staples, utilities, and healthcare sectors.

Read more »